|1.||Ma, Yinfa: 5 articles (01/2015 - 10/2009)|
|2.||Shi, Honglan: 3 articles (01/2015 - 11/2013)|
|3.||Burton, Casey: 3 articles (01/2015 - 11/2013)|
|4.||Wirleitner, B: 3 articles (04/2002 - 01/2000)|
|5.||Fuchs, D: 3 articles (04/2002 - 01/2000)|
|6.||Widner, B: 3 articles (04/2002 - 01/2000)|
|7.||Fuchs, Dietmar: 2 articles (01/2015 - 07/2002)|
|8.||Reibnegger, Gilbert: 1 article (01/2015)|
|9.||Tomšík, P: 1 article (09/2013)|
|10.||Solich, P: 1 article (09/2013)|
01/01/2015 - "Reibnegger and Fuchs regarding our recent publication "Normalization of urinary pteridines by urine specific gravity for early cancer detection [Clin. "
01/01/2015 - "A rebuttal to "A comment to 'Normalization of urinary pteridines by urine specific gravity for early cancer detection' [Clin. "
01/01/2015 - "A comment to "normalization of urinary pteridines by urine specific gravity for early cancer detection" [Clin. "
08/05/2014 - "Normalization of urinary pteridines by urine specific gravity for early cancer detection."
01/14/2011 - "Pteridines are important cofactors in the process of cell metabolism, and they have recently become a focal point of cancer screening research because certain pteridine levels have been shown to reflect the presence of cancers. "
|3.||Breast Neoplasms (Breast Cancer)
11/19/2013 - "In this study, a simple, rapid, specific, and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method has been developed and optimized for simultaneous detection of six pteridines previously implicated in breast cancer and creatinine as a renal dilution factor in urine. "
11/19/2013 - "Recent preliminary studies have implicated urinary pteridines as candidate biomarkers in a growing number of malignancies including breast cancer. "
11/19/2013 - "The proposed technique was finally compared directly with a previously reported CE-LIF technique, concluding that additional or alternative renal dilution factors are needed for proper investigation of urinary pteridines as breast cancer biomarkers. "
11/19/2013 - "Simultaneous detection of six urinary pteridines and creatinine by high-performance liquid chromatography-tandem mass spectrometry for clinical breast cancer detection."
05/10/2005 - "Human mammary carcinoma MCF-7 cell line responsiveness to the pteridines xanthopterin and isoxanthopterin was studied using the MTS assay for measurement of cell viability. "
01/01/1994 - "[Unconjugated pteridines and neuromeningeal infections]."
01/01/1993 - "[Unconjugated pteridines and neuromeningeal infections]."
06/30/1989 - "Recently, it has been shown that pteridines also are involved in immunological responses, and neopterin has been suggested as a diagnostic marker for malignancies, virus infections and acute rejection episodes following allotransplantation."
09/01/2013 - "Pteridines are a group of endogenous heterocyclic compounds whose concentrations in biological fluids may be increased in some disorders, such as infections, autoimmune disorders and cancer. "
|4.||Biological Markers (Surrogate Marker)
|9.||O-(chloroacetylcarbamoyl)fumagillol (TNP 470)
|1.||Renal Replacement Therapy (Therapies, Renal Replacement)
|2.||Drug Therapy (Chemotherapy)